AKTX

Akari Therapeutics News

Company Name Stock Ticker Symbol Market Type
Akari Therapeutics PLC AKTX NASDAQ Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 1.4851 04:00:04
Open Price Low Price High Price Close Price Prev Close
1.4851
more quote information »

Recent News

Date Time Source Heading
7/29/202217:01EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/20/202216:43EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/08/202206:02EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
7/05/202217:22EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/16/202206:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
6/13/202207:00GLOBEAkari Therapeutics Announces the Appointment of Accomplished..
6/07/202206:05EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/20/202216:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/19/202216:05GLOBEAkari Therapeutics Presents Results from the CASCADE and..
5/16/202206:43EDGARAnnual and Transition Report (foreign Private Issuer) (20-f)
5/16/202206:00GLOBEAkari Therapeutics Reports Full Year 2021 Financial Results..
5/11/202208:53EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/11/202207:00GLOBEAkari Therapeutics to Present Results from Compassionate Use..
5/10/202207:00GLOBEAkari Therapeutics Announces Publication of Phase II Data of..
5/09/202216:53EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
5/09/202207:00GLOBEAkari Presents Results from Two Preclinical Development..
4/29/202217:11EDGARNotification That Form 20-f Will Be Submitted Late (nt 20-f)
3/21/202208:00GLOBEAkari Therapeutics to Present on Two Ongoing Programs..
3/10/202206:12EDGARProspectus Filed Pursuant to Rule 424(b)(5) (424b5)
3/10/202206:12EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/09/202207:30GLOBEAkari Therapeutics Announces New Data Supporting Use of Drug..
3/08/202213:12SEEKAkari Therapeutics slips on $9M equity offering
3/08/202211:45GLOBEAkari Therapeutics, Plc Announces $9.0 Million Registered..
3/04/202216:58EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
3/02/202207:29SEEKAkari Therapeutics picks new CEO
3/02/202207:00GLOBEAkari Therapeutics Appoints Rachelle Jacques as President..
2/28/202217:49EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
2/28/202209:12GLOBEAkari Therapeutics Announces New Data Showing A Significant..
2/11/202207:00GLOBEAkari Therapeutics to Present at BIO CEO & Investor..
1/26/202216:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/26/202212:11SEEKAkari advances program for inhaled delivery of nomacopan for..
1/26/202208:30GLOBEAkari Advances Lung Program with Inhaled Nomacopan Focused..
1/19/202216:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
1/19/202214:52SEEKAkari says FDA agrees to use of new manufacturing process..
1/19/202208:30GLOBEFDA Agrees to Use of New Higher-Yielding Manufacturing..
1/14/202216:19EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
1/07/202216:08EDGARSecurities Registration (ads, Immediate) (f-6ef)
1/04/202207:00GLOBEAkari Therapeutics to Present at H.C. Wainwright BioConnect..
1/04/202206:04EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/30/202113:02SEEKAkari Therapeutics to raise $6M in ADSs offering
12/30/202111:03GLOBEAkari Therapeutics, Plc Announces $6.0 Million Registered..
12/03/202116:31EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/03/202107:55SEEKAkari Therapeutics reports Q3 results
12/03/202107:45GLOBEAkari Therapeutics Reports Third Quarter 2021 Financial..
12/01/202117:17EDGARReport of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16..
12/01/202108:30GLOBEAkari Therapeutics Presents New Data Revealing Potential..
10/26/202108:00GLOBEAkari Therapeutics Announces Presentation at Annual..
10/25/202108:30GLOBEAkari Therapeutics Announces New Data with Nomacopan from..
10/18/202117:07EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
9/30/202117:04EDGARPost-effective Amendment to Registration Statement (pos Am)


Your Recent History
NASDAQ
AKTX
Akari Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now